The benchmark S&P 500 index keeps reaching new highs, but not all of its components have participated in the rally. Royalty ...

Westminster Council report says divesting pension fund from companies linked to Israel and occupation of Palestinian ...

Private equity group Carlyle has joined forces with other investors on a €900 million-plus recapitalisation of UK drugmaker ...

Fintel reports that on December 12, 2024, UBS upgraded their outlook for West Pharmaceutical Services (NYSE:WST) from Neutral ...

It would cost $472 million per year to cover medication-assisted addiction treatment under a plan Baltimore is hoping a court ...

More than 233,000 bottles of an antidepressant have been recalled by the FDA due to the presence of duloxetine posing the risk of cancer.

At Pharmapack Europe, TekniPlex Healthcare plans to tout its expanded capacity for injection blow molded bottles and ...

Inovio Pharmaceuticals shares were down 20% to $2.99 after hours as the company said it plans to sell stock and accompanying warrants.

The Danish biopharma company on Thursday said the FDA accepted its supplemental biologics application in adult growth hormone deficiency for TransCon hGH, which is marketed as Skytrofa for pediatric ...

Policy experts punched holes in drug companies' claims that the Medicare Drug Price Negotiation Program will stunt innovation ...

Gilead Sciences said on Thursday it has appointed Sanofi's Dietmar Berger as its chief medical officer, replacing incumbent ...

In May, Glenmark recalled nearly 47 million potassium chloride capsules due to a defect causing improper dissolution, which could lead to life-threatening spikes in potassium levels. Potassium ...